Arizona State Retirement System’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-25,603
| Closed | -$115K | – | 2103 |
|
|
2026
Q1 | $115K | Sell |
25,603
-70
| -0.3% | -$365 | ﹤0.01% | 2004 |
|
|
2025
Q4 | $158K | Sell |
25,673
-1,580
| -6% | -$11.5K | ﹤0.01% | 1972 |
|
|
2025
Q3 | $197K | Buy |
27,253
+414
| +2% | +$2.46K | ﹤0.01% | 1961 |
|
|
2025
Q2 | $143K | Buy |
26,839
+774
| +3% | +$4.57K | ﹤0.01% | 1985 |
|
|
2025
Q1 | $231K | Sell |
26,065
-277
| -1% | -$3.33K | ﹤0.01% | 1821 |
|
|
2024
Q4 | $361K | Buy |
26,342
+280
| +1% | +$5.17K | ﹤0.01% | 1656 |
|
|
2024
Q3 | $714K | Buy |
26,062
+902
| +4% | +$24.4K | ﹤0.01% | 1296 |
|
|
2024
Q2 | $615K | Buy |
25,160
+829
| +3% | +$18.2K | ﹤0.01% | 1311 |
|
|
2024
Q1 | $519K | Buy |
24,331
+1,440
| +6% | +$31K | ﹤0.01% | 1426 |
|
|
2023
Q4 | $438K | Sell |
22,891
-330
| -1% | -$5.71K | ﹤0.01% | 1531 |
|
|
2023
Q3 | $372K | Buy |
23,221
+316
| +1% | +$6.01K | ﹤0.01% | 1544 |
|
|
2023
Q2 | $531K | Sell |
22,905
-574
| -2% | -$12.5K | ﹤0.01% | 1371 |
|
|
2023
Q1 | $545K | Buy |
23,479
+726
| +3% | +$14.7K | ﹤0.01% | 1352 |
|
|
2022
Q4 | $330K | Buy |
22,753
+920
| +4% | +$17.1K | ﹤0.01% | 1613 |
|
|
2022
Q3 | $417K | Buy |
21,833
+147
| +0.7% | +$3.37K | ﹤0.01% | 1432 |
|
|
2022
Q2 | $394K | Buy |
21,686
+100
| +0.5% | +$2.08K | ﹤0.01% | 1505 |
|
|
2022
Q1 | $544K | Buy |
21,586
+578
| +3% | +$14.8K | ﹤0.01% | 1412 |
|
|
2021
Q4 | $580K | Buy |
21,008
+20
| +0.1% | +$579 | ﹤0.01% | 1442 |
|
|
2021
Q3 | $678K | Buy |
20,988
+544
| +3% | +$18.1K | 0.01% | 1346 |
|
|
2021
Q2 | $625K | Sell |
20,444
-1,450
| -7% | -$41.9K | 0.01% | 1430 |
|
|
2021
Q1 | $667K | Buy |
21,894
+248
| +1% | +$7.04K | 0.01% | 1379 |
|
|
2020
Q4 | $428K | Sell |
21,646
-849
| -4% | -$13.7K | ﹤0.01% | 1545 |
|
|
2020
Q3 | $293K | Buy |
22,495
+5,668
| +34% | +$71.7K | ﹤0.01% | 1602 |
|
|
2020
Q2 | $191K | Sell |
16,827
-637
| -4% | -$9.05K | ﹤0.01% | 1668 |
|
|
2020
Q1 | $250K | Sell |
17,464
-32,141
| -65% | -$679K | ﹤0.01% | 1401 |
|
|
2019
Q4 | $1.35M | Sell |
49,605
-37,148
| -43% | -$1.02M | 0.02% | 944 |
|
|
2019
Q3 | $2.48M | Sell |
86,753
-27,064
| -24% | -$789K | 0.03% | 750 |
|
|
2019
Q2 | $3.16M | Buy |
113,817
+785
| +0.7% | +$22.2K | 0.04% | 695 |
|
|
2019
Q1 | $3.75M | Sell |
113,032
-2,101
| -2% | -$64K | 0.04% | 559 |
|
|
2018
Q4 | $3.35M | Buy |
115,133
+12,254
| +12% | +$441K | 0.04% | 575 |
|
|
2018
Q3 | $4.73M | Buy |
102,879
+1,113
| +1% | +$49.5K | 0.04% | 510 |
|
|
2018
Q2 | $3.8M | Sell |
101,766
-8,414
| -8% | -$284K | 0.04% | 610 |
|
|
2018
Q1 | $3.26M | Sell |
110,180
-6,200
| -5% | -$210K | 0.03% | 711 |
|
|
2017
Q4 | $4M | Buy |
116,380
+80,870
| +228% | +$2.73M | 0.04% | 630 |
|
|
2017
Q3 | $1.28M | Hold |
35,510
| – | – | 0.02% | 915 |
|
|
2017
Q2 | $918K | Hold |
35,510
| – | – | 0.01% | 984 |
|
|
2017
Q1 | $682K | Buy |
+35,510
| New | +$629K | 0.01% | 1117 |
|
Other funds holding MYGN
VPC
Arizona State Retirement System's MYGN Position: Q2 2026 in Review
Arizona State Retirement System sold out of Myriad Genetics (MYGN) in Q2 2026, closing a stake of 25,603 shares — an estimated $115K sold.
Arizona State Retirement System first reported a position in MYGN in Q1 2017 and held it in 37 quarters. The position peaked at $4.73M in Q3 2018. 196 funds tracked by Wall St. Rank hold MYGN as of Q2 2026.
- Arizona State Retirement System reported no remaining Myriad Genetics position as of Q2 2026 after selling out during the quarter.
- Arizona State Retirement System sold 25,603 Myriad Genetics shares in Q2 2026, an estimated $115K.
- Arizona State Retirement System first reported a position in Myriad Genetics in Q1 2017 and held it in 37 quarters.
- Arizona State Retirement System's Myriad Genetics position peaked at $4.73M in Q3 2018.
- 196 funds tracked by Wall St. Rank held Myriad Genetics as of Q2 2026.
Based on Arizona State Retirement System's 13F filing for Q2 2026, filed 7 Aug 2026.